logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (ii) New outpatient clients, primary drug distribution by age (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids1.89.827.936.038.742.944.540.4455643001
Cocaine2.18.521.529.735.333.931.527.836583501
Stimulants2.54.75.65.04.53.43.53.2651617
Hypnotics and sedatives0.91.11.11.21.42.12.99.6294742
Hallucinogens0.20.50.60.40.20.10.10.250810
Volatile substances6.10.70.10.10.10.10.10.143414
Cannabis 86.174.242.526.819.115.815.313.149792717
Other substances 0.40.60.70.70.71.62.05.617851262
Total2549233423030128318219701611611113104201441295564

Notes:

 The countries supplying data are: 

 AT; BE; BG; HR; CY; CZ; DK; EE; FI; FR; DE; GR; HU; IE; IT; LV; MT; NL; PL; RO; SK; SI; ES; SE; UK 

 Data for Spain refer to 2008 and to outpatient centres and treatment units in prisons. Data for the Netherlands refer to outpatient centres, inpatient centres and low-threshold agencies. Data for Estonia refer to outpatient and inpatient centres. Data for Malta refer to outpatient and inpatient centres and low-threshold and prison units. Data for Poland refer to 2008 and to 33 health care units. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-102 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011